Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831424 · ClinicalTrials.gov registry record · NA
Mitochondrial Stress, Brain Imaging, and Epigenetics
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT04831424 is a NA study that has completed, run by Columbia University. The registered enrollment target is 110 participants.
The verdict
NCT04831424, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The MiSBIE study collects biological, behavioral, psychosocial, neuropsychological, and brain imaging data in participants with either: normal mitochondrial function, individuals with the m.3243A\>G mitochondrial DNA (mtDNA) mutation, and individuals a single large-scale mtDNA deletion. These defects induce mitochondrial allostatic load (MAL). The 2-day protocol, plus home-based data collection, will provide a comprehensive assessment of the multi-systemic dysregulation associated with MAL or mitochondrial dysfunction, and the link to physical and mental health-related symptoms. Aim 1: Determine the influence of MAL on systemic AL biomarkers. Aim 2: Establish the influence of MAL on stress reactivity profiles. Aim 3. Examine the association between MAL and psychological functioning.
Interventions
- BEHAVIORAL Trier social stress test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-06-12 |
| Est. Completion | 2024-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04831424
The ClinicalTrials.gov registry entry for NCT04831424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trier social stress test is the first listed.
NCT04831424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04831424 about?
NCT04831424 is a clinical study titled "Mitochondrial Stress, Brain Imaging, and Epigenetics". The MiSBIE study collects biological, behavioral, psychosocial, neuropsychological, and brain imaging data in participants with either: normal mitochondrial function, individuals with the m.3243A\>G mitochondrial DNA (mtDNA) mutation, and individuals a single large-scale mtDNA deletion. These defect...
What is the current status of trial NCT04831424?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2018-06-12. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT04831424?
The interventions under investigation include: Trier social stress test (BEHAVIORAL).
Who is sponsoring clinical trial NCT04831424?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.